Free Trial
NYSEARCA:BOUT

Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News

$36.38 -0.20 (-0.55%)
As of 07/11/2025 04:10 PM Eastern

About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Key Stats

Today's Range
$36.37
$36.44
50-Day Range
$33.72
$36.92
52-Week Range
$31.08
$42.41
Volume
887 shs
Average Volume
2,269 shs
Market Capitalization
$10.91 million
Assets Under Management
$10.97 million
Dividend Yield
0.63%
Net Expense Ratio
0.85%
Aggregate Rating
Moderate Buy

ETF Overview

Innovator IBD Breakout Opportunities ETF Expenses

TypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.80%0.47%0.56%0.51%0.53%
Other Expenses0.05%0.49%0.56%0.59%0.56%
Total Expense0.85%0.67%0.76%0.74%0.73%
Fee Waiver0.00%-0.59%-0.66%-0.71%-0.63%
Net Expense0.85%0.53%0.63%0.58%0.60%
Receive BOUT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter.

BOUT ETF News Headlines

AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

BOUT ETF - Frequently Asked Questions

Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 at the beginning of the year. Since then, BOUT stock has decreased by 6.9% and is now trading at $36.38.

Innovator IBD Breakout Opportunities ETF's top institutional shareholders include Nova Wealth Management Inc. (1.66%).

Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET).

Fund Details

Issuer
Innovator Capital Management
Fund Name
Innovator IBD Breakout Opportunities ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BOUT
Inception Date
9/13/2018
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
IBD Breakout Stocks Index
Category
Broad Equity
Focus
Strategy
Development Level
Developed Markets
Region
North America
Number of Holdings
165

Fund Statistics

Assets Under Management
$10.97 million
Average Daily Volume
$1.19 thousand
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Innovator Capital Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
100 shs

Miscellaneous

Beta
0.98
Creation Unit
50,000
Creation Fee
$250.00
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Top 10 BOUT Holdings

BOUT Sector Exposure

BOUT Industry Exposure


This page (NYSEARCA:BOUT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners